Is NovaBay Pharmaceuticals Inc halal to invest in?

According to Musaffa's Shariah screening methodology, NovaBay Pharmaceuticals Inc (NBY) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is NovaBay Pharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes NovaBay Pharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of NovaBay Pharmaceuticals Inc?

Muslim investors may consider investing in NovaBay Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is NovaBay Pharmaceuticals Inc classified as HALAL?

Musaffa determines the Shariah status of NovaBay Pharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for NovaBay Pharmaceuticals Inc updated?

The Shariah compliance status of NovaBay Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like NovaBay Pharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of NovaBay Pharmaceuticals Inc?

You can check the latest Shariah compliance status of NovaBay Pharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

NBY Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: March 25, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for NovaBay Pharmaceuticals Inc (NBY)

Based on 5 analysts giving stock ratings to NovaBay Pharmaceuticals Inc in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

NovaBay Pharmaceuticals Inc. Stock Analysis NBY

United States Health Care Nano Cap Report: 2025 Annual

NovaBay Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.

Key Statistics of NovaBay Pharmaceuticals Inc (NBY)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.57$1.98

Today's Open

$1.58

Volume

69.99K

P/E Ratio (TTM)

52 Week Range

$1.11$99.75

Market Cap

39.94M

Avg. Volume

122.79K

Dividend Yield

Financial Metrics & Statements of NovaBay Pharmaceuticals Inc (NBY)

FAQ's for NovaBay Pharmaceuticals Inc (NBY)

According to Musaffa’s Shariah screening methodology, NovaBay Pharmaceuticals Inc (NBY) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.